Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $66.00 at Needham & Company LLC
Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its target price increased by Needham & Company LLC from $64.00 to $66.00 in a research note released on Tuesday, Marketbeat reports. Needham & Company LLC currently has a buy rating on the stock. RYTM has been the topic of several other reports. The Goldman Sachs Group raised […]
Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its target price increased by Needham & Company LLC from $64.00 to $66.00 in a research note released on Tuesday, Marketbeat reports. Needham & Company LLC currently has a buy rating on the stock. RYTM has been the topic of several other reports. The Goldman Sachs Group raised […]
